Results 91 to 100 of about 9,845,002 (301)

Maternal pelvic size not predictive of daughter's breast cancer or ovarian cancer in a large Swedish cohort. [PDF]

open access: yes, 2009
Recent studies from Finland reported that maternal pelvic size predicted daughters' breast and ovarian cancer, possibly because maternal pelvic size is a marker for in utero hormone exposure.
Goodman, Anna   +8 more
core   +1 more source

Adherence to Mediterranean Diet and Breast Cancer Risk: A Meta‐Analysis of Prospective Observational Studies

open access: yesHealth Science Reports
Background and Aim The Mediterranean diet (MD) is widely recognized for its health benefits and potential protective effects against various chronic diseases such as cardiovascular conditions and cancer.
Mehdi Karimi   +8 more
doaj   +1 more source

Occurrence, Dietary Risk Assessment and Cancer Risk Estimates of Aflatoxins and Ochratoxin A in Powdered Baby Foods Consumed in Turkey

open access: yesToxins
In this study, the aim was to determine the levels of aflatoxins and ochratoxin A (OTA) in baby food consumed in Hatay using fluorescence-detector HPLC (HPLC-FLD) and to reveal the health risks that may occur in babies through consumption of these foods.
Çiğdem El, Seydi Ahmet Şengül
doaj   +1 more source

Some Molecular and Clinical Aspects of Genetic Predisposition to Malignant Melanoma and Tumours of Various Site of Origin

open access: yesHereditary Cancer in Clinical Practice, 2007
Based on epidemiological data we can assume that at least some malignant melanoma (MM) and breast cancer cases can be caused by the same genetic factors.
Dębniak Tadeusz
doaj   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

Analysis of Over 140,000 European Descendants Identifies Genetically Predicted Blood Protein Biomarkers Associated with Prostate Cancer Risk.

open access: yes, 2019
Several blood protein biomarkers have been associated with prostate cancer risk. However, most studies assessed only a small number of biomarkers and/or included a small sample size.
Eeles, RA   +8 more
core   +1 more source

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. [PDF]

open access: yes, 2012
Several common alleles have been shown to be associated with breast and/or ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. Recent genome-wide association studies of breast cancer have identified eight additional breast cancer susceptibility ...
Dutra-Clarke, Ana   +999 more
core   +4 more sources

Aspartame and Human Health: A Mini-Review of Carcinogenic and Systemic Effects

open access: yesJournal of Xenobiotics
Aspartame, a widely used artificial sweetener, has been at the center of ongoing debates concerning its safety, particularly its potential role in cancer development.
Nour El Doueihy   +9 more
doaj   +1 more source

Re-Evaluating the Association Between Hormonal Contraception and Breast Cancer Risk

open access: yesBreast Cancer: Targets and Therapy, 2023
Sanjana Satish,1 Jessica F Moore,2 Jay M Littlefield,3 Ian J Bishop,2 Kristin E Rojas2,4 1University of Miami Miller Medical School, Miami, FL, USA; 2Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Miami Miller School of ...
Satish S   +4 more
doaj  

Epigenetic reprogramming of lineage switching in cancer

open access: yesFEBS Letters, EarlyView.
Cancer cells rarely commit to a single identity. Epigenetic mechanisms and tumor microenvironment cues push epithelial cells toward flexible, hybrid states that can shift into mesenchymal, neuroendocrine, or stem‐like fates, driving metastasis, drug resistance, and tumor heterogeneity. Targeting the epigenetic regulators behind these transitions, using
Ezgi Boyvatlı   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy